{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:48:26Z","timestamp":1793828906618,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.seizure.2020.11.006","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T18:42:56Z","timestamp":1605811376000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL"],"prefix":"10.1016","volume":"84","author":[{"given":"Xiao-hang","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-dong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2020.11.006_bib0005","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41436-018-0143-0","article-title":"De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy","volume":"21","author":"Tran Mau-Them","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.seizure.2020.11.006_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2019.09.020","article-title":"IRF2BPL mutations cause autosomal dominant dystonia with anarthria, slow saccades and seizures","volume":"68","author":"Ganos","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.seizure.2020.11.006_bib0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11033-019-05109-7","article-title":"A novel IRF2BPL truncating variant is associated with endolysosomal storage","volume":"47","author":"Ginevrino","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.seizure.2020.11.006_bib0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajhg.2018.08.010","article-title":"IRF2BPL is associated with neurological phenotypes","volume":"103","author":"Marcogliese","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.seizure.2020.11.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2020.03.030","article-title":"IRF2BPL mutation causes nigrostriatal degeneration presenting with dystonia, spasticity and keratoconus","author":"Prilop","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.seizure.2020.11.006_bib0030","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/ajmg.a.61328","article-title":"IRF2BPL gene mutation: expanding on neurologic phenotypes","volume":"179","author":"Shelkowitz","year":"2019","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.seizure.2020.11.006_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ajmg.a.61401","article-title":"IRF2BPL gene variants: one new case","volume":"182","author":"Spagnoli","year":"2020","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.seizure.2020.11.006_bib0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.parkreldis.2019.01.017","article-title":"Neurodevelopmental disorder associated with IRF2BPL gene mutation: Expanding the phenotype?","volume":"62","author":"Skorvanek","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.seizure.2020.11.006_bib0045","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1006\/bbrc.2000.3883","article-title":"Characterization of C14orf4, a novel intronless human gene containing a polyglutamine repeat, mapped to the ARVD1 critical region","volume":"278","author":"Rampazzo","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.seizure.2020.11.006_bib0050","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1172\/JCI31752","article-title":"Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis","volume":"117","author":"Heger","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.seizure.2020.11.006_bib0055","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1210\/en.2011-1541","article-title":"Hypothalamic EAP1 (enhanced at puberty 1) is required for menstrual cyclicity in nonhuman primates","volume":"153","author":"Dissen","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.seizure.2020.11.006_bib0060","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/hmg\/ddy451","article-title":"EAP1 regulation of GnRH promoter activity is important for human pubertal timing","volume":"28","author":"Mancini","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.seizure.2020.11.006_bib0065","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1158\/0008-5472.CAN-17-2403","article-title":"Forkhead Box f2 suppresses gastric Cancer through a novel FOXF2-IRF2BPL-\u03b2-Catenin signaling Axis","volume":"78","author":"Higashimori","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.seizure.2020.11.006_bib0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.50985","article-title":"New phenotype of DCTN1-related spectrum: early-onset dHMN plus congenital foot deformity","volume":"7","author":"Tian","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2020.11.006_bib0075","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.seizure.2020.11.006_bib0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.seizure.2020.11.006_bib0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tibs.2011.11.001","article-title":"RINGs hold the key to ubiquitin transfer","volume":"37","author":"Budhidarmo","year":"2012","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.seizure.2020.11.006_bib0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-59745-406-3_14","article-title":"The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus","volume":"463","author":"von Mikecz","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.seizure.2020.11.006_bib0095","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajhg.2017.01.003","article-title":"De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental Disorder","volume":"100","author":"K\u00fcry","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.seizure.2020.11.006_bib0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fnagi.2016.00303","article-title":"Dysregulation of ubiquitin-proteasome system in neurodegenerative diseases","volume":"8","author":"Zheng","year":"2016","journal-title":"Front Aging Neurosci"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131120303551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131120303551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:56:38Z","timestamp":1761011798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131120303551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":20,"alternative-id":["S1059131120303551"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2020.11.006","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2020.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}